We concur with Dackis and O'Brien's view that prefrontal cortex dysfunction represents a cardinal feature of cocaine abuse. Although in vivo recordings from our and others laboratories (Chang et al, 1997, 1998, 2000) implicate a common set of changes in electrophysiological indices in prefrontal cortex neurons after acute and chronic stimulant exposure, the precise synaptic mechanisms mediating these alterations remain unknown. We therefore emphasize the probable dependence of complex psychopathologic features of addiction on the canonical cortico-striatal-pallido-thalamo-cortical loops that are clearly implicated in many aspects of cognitive, motor, and affective function (Haber, 2003), and that are direct mediators of recidivism-like phenomena (Kalivas and Volkow, 2005).
Elegant work by Steriade and colleagues (Steriade and Deschenes, 1984; Steriade and Timofeev, 2003) indicates that thalamic inputs to the neocortex as well as cortico-cortical connections (Timofeev et al, 2000) are important regulators of spike activity, as well as of the bistable membrane potentials recorded from prefrontal neurons in vivo. When taken together with the growing evidence for direct actions of stimulant drugs on pallidal and thalamic neurons (Lavin and Grace, 1998), it becomes apparent that subcortical actions of addictive agents could disrupt cortical neuron function either directly or through complex multisynaptic actions. Indeed, Jentsch and Taylor (1999) have emphasized how drug effects on multiple cortical and subcortical brain regions may be required to sustain the compulsive aspects of drug addiction. We therefore additionally stress these larger circuit actions of stimulant drugs in the key psychological features of addiction noted by Dackis and O'Brien.
Much remains unknown about the subcellular causes of dysfunction of these neuronal loops. New work has emphasized mechanism implicating LTP (Borgland et al, 2004; Saal et al, 2003; Ungless et al, 2001), intracellular signaling proteins (Szumlinski et al, 2004; Bowers et al, 2004; Nestler, 2004), and monoamine neurotransmitters (Volkow et al, 2004). In vivo recordings will be but part of the experimental repertoire required to reveal these changes.
The authors thank Dr David J Jentsch for his valuable comments.
Borgland SL, Malenka RC, Bonci A (2004). Acute and chronic cocaine-induced potentiation of synaptic strength in the ventral tegmetal area: electrophysiological and behavioral correlates in individual rats. J Neurosci 24: 7482–7490.
Bowers MS, McFarland K, Lake RW, Peterson YK, Lapish CC, Gregory ML et al (2004). Activator of G protein signaling 3: a gatekeeper of cocaine sensitization and drug addiction. Neuron 42: 269–281.
Chang JY, Janak PH, Woodward DJ (1998). Comparison of mesocorticolimbic neuronal responses during cocaine and heroin self-administration in freely moving rats. J Neurosci 18: 3098–3115.
Chang JY, Janak PH, Woodward DJ (2000). Neuronal and behavioral correlations in the medial prefrontal cortex and nucleus accumbens during cocaine self-administration. Neuroscience 99: 433–443.
Chang JY, Sawyer SF, Paris JM, Kirillov A, Woodward DJ (1997). Single neuronal responses in medial prefrontal cortex during cocaine self-administration in freely moving rats. Synapse 26: 22–35.
Haber SN (2003). The primate basal ganglia: parallel and integrative networks. J Chem Neuroanat 26: 317–330.
Jentsch JD, Taylor JR (1999). Impulsivity resulting form frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychoparmacology 146: 373–390.
Kalivas PW, Volkow ND (2005). The neurobiology of addiction: a pathology of motivation and choice. Am J Psychiatry, (in press).
Lavin A, Grace AA (1998). response of the ventral pallidal/mediodorsal thalamic system to antipsychotic drug administration: involvement of the prefrontal cortex. Neuropsychopharmacology 18: 352–363.
Nestler E (2004). Molecular mechanism of drug addiction. Neuropharmacology 47(Suppl 1): 24–32.
Saal D, Dong Y, Bonci A, Malenka RC (2003). Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron 37: 577–582.
Steriade M, Deschenes M (1984). The thalamus as a neuronal oscillator. Brain Res 320: 1–63.
Steriade M, Timofeev I (2003). Neuronal plasticity in thalamocortical networks during sleep and waking oscillations. Neuron 20: 563–576.
Szumlinski KK, Dehoff MH, Kang SH, Frys KA, Lominac KD, Klugman M et al (2004). Homer protein regulates sensitivity to cocaine. Neuron 43: 401–413.
Timofeev I, Grenier F, Bazhenov M, Sejnowski TJ, Steriade M (2000). Origin of slow cortical oscillations in deafferented cortical slabs. Cerebral Cortex 10: 1185–1199.
Ungless MA, Whistler JL, Malenka RC, Bonci A (2001). Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature 411: 583–587.
Volkow ND, Fowler JS, Wang GJ, Swanson JM (2004). Dopamine in drug abuse and addiction: result from imaging studies and treatment implications. Mol Psychiatry 9: 557–569.
Rights and permissions
About this article
Cite this article
Lavin, A., Kalivas, P. Reply: Clinical Implications of Cocaine-Induced Cortical Depression. Neuropsychopharmacol 30, 1034–1035 (2005). https://doi.org/10.1038/sj.npp.1300702